You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Advancing a Glioma Immunotherapy
SBC: IN CYTU, INC. Topic: 102DESCRIPTION provided by applicant A Phase II SBIR program of preclinical development is proposed for the development of an active specific immunotherapeutic called Cellariumandquot for treatment of glial cell based cancers Successful completion of this project will confirm therapeutic effect and pre clinical safety of the vaccine in preparation for first in human studies Upon demonstration of ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF "ID CAP SYSTEM" PURPOSE TO EXTEND THE PERIOD OF PERFORMANCE FOR THREE ADDITIONAL MONTHS MODIFY CONTRACT CLAUSES IN SECTIONS B F AND G AND MAKE AN ADMINISTRATIVE CHANGE IN PRISM N D
SBC: ETECT, INC. Topic: NIDAe Tect has created a medication adherence monitoring system called ID Cap consisting of a tag smaller than the size of a postage stamp that can be wrapped around a capsule or attached to a pill When the tagged medication is ingested it activates and sends a signal to a reader worn on the arm The reader relays the signals securely to a remote database enabling accurate medication adherence monit ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Repurposing Pyrvinium as an Orphan Drug for Familial Adenomatous Polyposis
SBC: Stemsynergy Therapeutic Topic: 102DESCRIPTION provided by applicant The tumor suppressor Adenomatous Polyposis Coli APC directs degradation of catenin a central signaling protein in the WNT pathway Germline loss of function mutations in APC activate WNT signaling and underlie the inherited colorectal cancer predisposition syndrome Familial Adenomatous Polyposis FAP an orphan disease while somatic mutations lead to spo ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of nucleic acid delivery platform based on polymeric CXCR4 antagonists
SBC: Bohemica Pharmaceuticals, LLC Topic: 100DESCRIPTION provided by applicant Therapeutics based on nucleic acids NA promise to revolutionize treatment of multiple diseases but their widespread use is currently limited by the lack of efficient delivery methods We have recently developed a new NA delivery platform based on polymeric CXCR inhibitors PCX suitable as dual function systems for simultaneous NA delivery and inhibition of ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Mutation Enriched Targeted Re Sequencing
SBC: TRANSGENOMIC, INC. Topic: 103DESCRIPTION provided by applicant Low level tumor associated somatic DNA mutations can have profound implications for development of metastasis prognosis choice of treatment follow up or early cancer detection Unless they are effectively detected these low level mutations can misinform patient management decisions or become missed opportunities for personalized medicine Widely used tech ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Rapid and Simple Device for Point-of-Care Molecular Detection of Arboviruses
SBC: LUCIGEN CORPORATION Topic: NIAIDExpensive equipment highly trained personnel and the need for a clinical laboratory setting precludes routine nucleic acid testing NAT for infectious disease in most of the developing world and even in many resource limited parts of the United States leading to wide disparities in health care worldwide A fast sensitive low cost but a facile NAT method for robust detection of specific agent ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of a Non adjuvanted VLP Vaccine against Stealth H N Influenza
SBC: EPIVAX, INC. Topic: NIAIDDESCRIPTION provided by applicant The avian origin H N influenza virus that emerged in humans in China in presents a unique challenge to vaccine development because it is poorly immunogenic Neutralizing antibodies are not detected in acute phase infection Anti H antibody responses are significantly delayed and exhibit low avidity in comparison with antibodies generated following seas ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Microfluidic assay to predict patient-specific multiple myeloma clinical response
SBC: Lynx Biosciences, Inc. Topic: 102DESCRIPTION provided by applicant Multiple myeloma MM is a debilitating and currently incurable hematological malignancy While the median survival has increased to years MM patients ultimately relapse and become resistant to therapy Once they reach this stage it is often a trial and error process until an effective therapy can be found Furthermore the MM bone marrow tumor microenv ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A Formaldehyde Dosimeter for Personal Exposure Assessment
SBC: Platypus Technologies, LLC Topic: NIEHSDESCRIPTION provided by applicant The air we breathe can contain dozens of toxins The National Institute of Environmental Health Sciences NIEHS strategic plan for includes a major focus on andquot enhancing our ability to quantify individual exposures and responses to environmental toxins andquot Similarly the US Environmental Protection Agency EPA is increasing its emphasis on ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Optical imaging of a CD based oral rinse with fluorescent detection to visualize oral cancer
SBC: Vigilant Biosciences Topic: NIDCRDESCRIPTION provided by applicant Oral squamous cell carcinomas including those of the mouth and oropharynx comprise more than of all cancers affecting these tissues Of all the major cancers oral cancer has one of the worst five year survival rates of Historically the death rate associated with this cancer is particularly high because it is discovered late stage III or IV oft ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health